Table 1.
A control |
B rt-PA |
C rt-PA + US |
D TNK |
E TNK + US |
|
---|---|---|---|---|---|
weight loss ± SD [%] | 17.3 ± 7.4 | 28.3 ± 9.6 | 31.6 ± 10 | 34.5 ± 8 | 38.1 ± 6.7 |
area covered by fibrin ± SD [%] | 58 ± 5.2 | 54.7 ± 3.6 | 52.9 ± 6.5 | 42.3 ± 6 | 45.1 ± 2.3 |
Results for measured relative clot weight loss of different treatment groups (A-E) as well as for relative area covered by fibrin in TEM for the different treatment strategies are combined. SD: standard deviation from the mean. TNK: tenecteplase; US: color-coded sonography (2 MHz, 0.179 W/cm2)